For ibalizumab you may want to look at clinicaltri
Post# of 148166
(Total Views: 314)
Posted On: 07/02/2021 12:32:26 PM
For ibalizumab you may want to look at clinicaltrials.gov for the use of biomarkers as endpoints. They don't exist.
Quite a bad drug, how did it get approved?
Should be 2021.
No that isn't true. Any options or warrants from previous years are compensation for that year not when they are exercised.
Quite a bad drug, how did it get approved?
Quote:
Grade 3 or 4 adverse events were reported in 11 patients (28%), and acquired immunodeficiency syndrome (AIDS)–defining adverse events occurred in 4 patients (10%).
Quote:
I would hope that is typo instead of cut paste from cydy website
Should be 2021.
Quote:
They stated "total compensation" Is that not true??
No that isn't true. Any options or warrants from previous years are compensation for that year not when they are exercised.
(11)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼